STOCK TITAN

Carole Huntsman to sell 419 shares — Madrigal (NASDAQ: MDGL) Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Carole Huntsman submitted a Form 144 proposing the sale of 419 shares of common stock in Madrigal Pharmaceuticals. The filing lists a Restricted Stock Unit Grant with a 03/06/2026 vesting date tied to 419 shares. The filing also discloses prior sales of 340 and 570 shares on 01/26/2026.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Carole Huntsman's Form 144 for MDGL report?

It reports a proposed sale of 419 shares of common stock tied to a restricted stock unit vesting on 03/06/2026. The filing lists prior sales and identifies the securities and dates without stating planned sale price.

What recent sales by Carole Huntsman are disclosed in the filing?

The filing states sales of 340 shares and 570 shares executed on 01/26/2026, with corresponding amounts of $167,422.80 and $281,916.30 shown in the excerpt.

Does the Form 144 show when the 419 shares became available to sell?

Yes. The filing links the 419 shares to a Restricted Stock Unit grant vesting on 03/06/2026, which is the date shown for the securities to be sold.

Who is the broker or agent listed on the Form 144 for these transactions?

The excerpt lists Morgan Stanley Smith Barney LLC at 1 New York Plaza as the broker/firm associated with the securities to be sold and the Nasdaq as the market.